(PDF) Low Expression of Aldo–keto Reductase 1B10 Is a Novel

Low Expression of Aldo–keto Reductase 1B10 Is a Novel Independent Prognostic Indicator for Nasopharyngeal Carcinoma

Cell and Bioscience - United Kingdom

doi 10.1186/s13578-016-0082-x

Full Text

Abstract

Available in full text

Categories

Molecular Biology

Date

March 5, 2016

Authors

Publisher

Springer Science and Business Media LLC

Related search

The Identification of Human Aldo-Keto Reductase AKR7A2 as a Novel Cytoglobin-Binding Partner

Cellular and Molecular Biology Letters

Molecular Biology

English

Regulation of Aldo-Keto-Reductase Family 1 B10 by 14-3-3ε And Their Prognostic Impact of Hepatocellular Carcinoma

English

Interleukin 35 Is an Independent Prognostic Factor and a Therapeutic Target for Nasopharyngeal Carcinoma

Wspolczesna Onkologia

Nuclear Medicine

English

CDKN3 Expression Is an Independent Prognostic Factor and Associated With Advanced Tumor Stage in Nasopharyngeal Carcinoma

International Journal of Medical Sciences

English

Aldo-Keto Reductase 1C3 Is Overexpressed in Skin Squamous Cell Carcinoma (SCC) and Affects SCC Growth via Prostaglandin Metabolism

Experimental Dermatology

Molecular Biology

English

Expression of Interleukin-8, Interleukin-10 and Epstein-Barr Viral-Load as Prognostic Indicator in Nasopharyngeal Carcinoma

Global journal of health science

English

Low Serum miR-19a Expression as a Novel Poor Prognostic Indicator in Multiple Myeloma

International Journal of Cancer

Cancer Research

English

MRI-based Radiomics Signature Is a Quantitative Prognostic Biomarker for Nasopharyngeal Carcinoma

Scientific Reports

Multidisciplinary

English

Medium-Chain Dehydrogenase/Reductase and Aldo-Keto Reductase Scavenge Reactive Carbonyls in Synechocystis Sp. PCC 6803

Molecular Biology

Structural Biology

English